Clinical Trials Directory

Trials / Completed

CompletedNCT05989321

A New Approach for Catheter Ablation of Atrial Fibrillation

A New Approach for Catheter Ablation of Atrial Fibrillation: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
116 (actual)
Sponsor
The Second Affiliated Hospital of Kunming Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a retrospective cohort study of radiofrequency ablation for the treatment atrial fibrillation(AF). Based on the electrophysiological phenomena found in these cases, the investigators propose a hypothesis regarding the underlying electrophysiological mechanism of AF, as well as a novel approach for catheter ablation of AF.

Detailed description

The investigators propose a new electrophysiological mechanism for AF: the superposition hypothesis. The investigators tested this hypothesis by conducting the retrospective cohort study to determine if superposition potentials (SP) can identify the critical regions where AF is sustained and if ablating SPs can improves the long-term efficacy. The study consecutively collected patients with underwent the first catheter ablation for symptomatic AF in a university hospital from March 2021 to June 2022, including paroxysmal AF (lasting \<7 days), persistent AF (lasting \>7 days and \<1 year without electrical cardioversion) and long-term persistent AF (lasting \>1 year), aged between 18 and 80 years old. AF recurrence was evaluated at 3, 6, 9, and 12 months using 72-hour Holter monitoring at each clinic visit. The eligible patients were divided into two groups: the pulmonary vein isolation(PVI) alone group (n=56) and the PVI + SPs ablation group(n=60).Comprehensive clinical history and procedural data of patients were collected from electronic medical records.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVI alonepulmonary vein isolation
PROCEDUREPVI + SPs ablationpulmonary vein isolation + SPs ablation

Timeline

Start date
2021-01-01
Primary completion
2022-06-30
Completion
2022-07-15
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05989321. Inclusion in this directory is not an endorsement.